Predictors and Outcomes of Periprocedural Intracranial Hemorrhage after Stenting for Symptomatic Intracranial Atherosclerotic Stenosis

References

1. 1.↵
   1. Holmstedt CA,
   2. Turan TN,
   3. Chimowitz MI

   . Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol 2013;12:1106–14 doi:10.1016/S1474-4422(13)70195-9 pmid:24135208

   CrossRefPubMedGoogle Scholar
2. 2.↵
   1. Gao P,
   2. Wang T,
   3. Wang D, et al

   ; CASSISS Trial Investigators. Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS Randomized Clinical Trial. JAMA 2022;328:534–42 doi:10.1001/jama.2022.12000 pmid:35943472

   CrossRefPubMedGoogle Scholar
3. 3.↵
   1. Alexander MJ,
   2. Zauner A,
   3. Gupta R, et al

   . The WOVEN trial: Wingspan One-year Vascular Events and Neurologic Outcomes. J Neurointerv Surg 2020;13:307–10 doi:10.1136/neurintsurg-2020-016208 pmid:32561658

   CrossRefPubMedGoogle Scholar
4. 4.↵
   1. Alexander MJ,
   2. Zauner A,
   3. Chaloupka JC, et al

   ; WEAVE Trial Sites and Interventionalists. WEAVE Trial: final results in 152 on-label patients. Stroke 2019;50:889–94 doi:10.1161/STROKEAHA.118.023996 pmid:31125298

   CrossRefPubMedGoogle Scholar
5. 5.↵
   1. Liu L,
   2. Wang D,
   3. Wong KS, et al

   . Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 2011;42:3651–54 doi:10.1161/STROKEAHA.111.635755 pmid:22052510

   Abstract/FREE Full TextGoogle Scholar
6. 6.↵
   1. Zhou M,
   2. Wang H,
   3. Zeng X, et al

   . Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019;394:1145–58 doi:10.1016/S0140-6736(19)30427-1 pmid:31248666

   CrossRefPubMedGoogle Scholar
7. 7.↵
   1. Redon J,
   2. Olsen MH,
   3. Cooper RS, et al

   . Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure. Eur Heart J 2011;32:1424–31 doi:10.1093/eurheartj/ehr045 pmid:21487117

   CrossRefPubMedWeb of ScienceGoogle Scholar
8. 8.↵
   1. Ssi-Yan-Kai G,
   2. Nasr N,
   3. Faury A, et al

   . Intracranial artery stenosis or occlusion predicts ischemic recurrence after transient ischemic attack. AJNR Am J Neuroradiol 2013;34:185–90 doi:10.3174/ajnr.A3144 pmid:22678847

   Abstract/FREE Full TextGoogle Scholar
9. 9.↵
   1. Zaidat OO,
   2. Klucznik R,
   3. Alexander MJ, et al

   ; NIH Multi-center Wingspan Intracranial Stent Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008;70:1518–24 doi:10.1212/01.wnl.0000306308.08229.a3 pmid:18235078

   Abstract/FREE Full TextGoogle Scholar
10. 10.↵
    1. Fiorella DJ,
    2. Turk AS,
    3. Levy EI, et al

    . U.S. Wingspan Registry: 12-month follow-up results. Stroke 2011;42:1976–81 doi:10.1161/STROKEAHA.111.613877 pmid:21636812

    Abstract/FREE Full TextGoogle Scholar
11. 11.↵
    1. Bose A,
    2. Hartmann M,
    3. Henkes H, et al

    . A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007;38:1531–37 doi:10.1161/STROKEAHA.106.477711 pmid:17395864

    Abstract/FREE Full TextGoogle Scholar
12. 12.↵
    1. Fiorella D,
    2. Derdeyn CP,
    3. Lynn MJ, et al

    ; SAMMPRIS Trial Investigators. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke 2012;43:2682–88 doi:10.1161/STROKEAHA.112.661173 pmid:22984008

    Abstract/FREE Full TextGoogle Scholar
13. 13.↵
    1. Derdeyn CP,
    2. Fiorella D,
    3. Lynn MJ, et al

    ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery 2013;72:777–95 doi:10.1227/NEU.0b013e318286fdc8 pmid:23328689

    CrossRefPubMedWeb of ScienceGoogle Scholar
14. 14.↵
    1. Zaidat OO,
    2. Fitzsimmons BF,
    3. Woodward BK, et al

    ; VISSIT Trial Investigators. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA 2015;313:1240–48 doi:10.1001/jama.2015.1693 pmid:25803346

    CrossRefPubMedGoogle Scholar
15. 15.↵
    1. Xu S,
    2. Wu P,
    3. Shi H, et al

    . Hyperperfusion syndrome after stenting for intracranial artery stenosis. Cell Biochem Biophys 2015;71:1537–42 doi:10.1007/s12013-014-0377-7 pmid:25398593

    CrossRefPubMedGoogle Scholar
16. 16.↵
    1. Alexander MJ,
    2. Yu W

    . Intracranial atherosclerosis update for neurointerventionalists. J Neurointerv Surg 2023;16:522–28 doi:10.1136/jnis-2022-019628 pmid:37295944

    CrossRefPubMedGoogle Scholar
17. 17.↵
    1. Miao Z,
    2. Zhang Y,
    3. Shuai J, et al

    ; Study Group of Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China. Thirty-day outcome of a multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China. Stroke 2015;46:2822–29 doi:10.1161/STROKEAHA.115.010549 pmid:26286544

    Abstract/FREE Full TextGoogle Scholar
18. 18.↵
    1. Sun X,
    2. Zhang J,
    3. Tong X, et al

    . A comparison between acute large vessel occlusion in the posterior circulation and anterior circulation after endovascular treatment: the ANGEL-ACT registry experience. Stroke Vasc Neurol 2022;7:285–93 doi:10.1136/svn-2021-001093 pmid:35260439

    Abstract/FREE Full TextGoogle Scholar
19. 19.↵
    1. Lin YH,
    2. Liu HM

    . Update on cerebral hyperperfusion syndrome. J Neurointerv Surg 2020;12:788–93 doi:10.1136/neurintsurg-2019-015621 pmid:32414892

    Abstract/FREE Full TextGoogle Scholar
20. 20.↵
    1. Claassen JAHR,
    2. Thijssen DHJ,
    3. Panerai RB, et al

    . Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation. Physiol Rev 2021;101:1487–559 doi:10.1152/physrev.00022.2020 pmid:33769101

    CrossRefPubMedGoogle Scholar
21. 21.↵
    1. Avolio A,
    2. Kim MO,
    3. Adji A, et al

    . Cerebral haemodynamics: effects of systemic arterial pulsatile function and hypertension. Curr Hypertens Rep 2018;20:20 doi:10.1007/s11906-018-0822-x pmid:29556793

    CrossRefPubMedGoogle Scholar
22. 22.↵
    1. Hawkes MA,
    2. Anderson CS,
    3. Rabinstein AA

    . Blood pressure variability after cerebrovascular events: a possible new therapeutic target: a narrative review. Neurology 2022;99:150–60 doi:10.1212/WNL.0000000000200856 pmid:35879090

    Abstract/FREE Full TextGoogle Scholar
23. 23.↵
    1. Castro P,
    2. Azevedo E,
    3. Sorond F

    . Cerebral autoregulation in stroke. Curr Atheroscler Rep 2018;20:37 doi:10.1007/s11883-018-0739-5 pmid:29785667

    CrossRefPubMedGoogle Scholar
24. 24.↵
    1. Xiong L,
    2. Liu X,
    3. Shang T, et al

    . Impaired cerebral autoregulation: measurement and application to stroke. J Neurol Neurosurg Psychiatry 2017;88:520–31 doi:10.1136/jnnp-2016-314385 pmid:28536207

    Abstract/FREE Full TextGoogle Scholar
25. 25.↵
    1. Pu Y,
    2. Lan L,
    3. Leng X, et al

    . Intracranial atherosclerosis: from anatomy to pathophysiology. Int J Stroke 2017;12:236–45 doi:10.1177/1747493016685716 pmid:28067615

    CrossRefPubMedGoogle Scholar
26. 26.↵
    1. Simpson DM,
    2. Payne SJ,
    3. Panerai RB

    . The INfoMATAS project: methods for assessing cerebral autoregulation in stroke. J Cereb Blood Flow Metab 2022;42:411–29 doi:10.1177/0271678X211029049 pmid:34279146

    CrossRefPubMedGoogle Scholar
27. 27.↵
    1. Nogueira RC,
    2. Aries M,
    3. Minhas JS, et al

    . Review of studies on dynamic cerebral autoregulation in the acute phase of stroke and the relationship with clinical outcome. J Cereb Blood Flow Metab 2022;42:430–53 doi:10.1177/0271678X211045222 pmid:34515547

    CrossRefPubMedGoogle Scholar
28. 28.↵
    1. Jiang X,
    2. Andjelkovic AV,
    3. Zhu L, et al

    . Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol 2018;163-164:144–71 doi:10.1016/j.pneurobio.2017.10.001 pmid:28987927

    CrossRefPubMedGoogle Scholar
29. 29.↵
    1. Sweeney MD,
    2. Zhao Z,
    3. Montagne A, et al

    . Blood-brain barrier: from physiology to disease and back. Physiol Rev 2019;99:21–78 doi:10.1152/physrev.00050.2017 pmid:30280653

    CrossRefPubMedGoogle Scholar
30. 30.↵
    1. Xiao Y,
    2. Rivaz H,
    3. Kasuya H, et al

    . Intra-operative video characterization of carotid artery pulsation patterns in case series with post-endarterectomy hypertension and hyperperfusion syndrome. Transl Stroke Res 2018;9:452–58 doi:10.1007/s12975-017-0605-8 pmid:29322480

    CrossRefPubMedGoogle Scholar
31. 31.↵
    1. Diana F,
    2. Frauenfelder G,
    3. Botto A, et al

    . Cerebral hyperperfusion syndrome after intracranial stenting: Case report and systematic review. Interv Neuroradiol 2021;27:843–49 doi:10.1177/15910199211011860 pmid:33884930

    CrossRefPubMedGoogle Scholar
32. 32.↵
    1. Li J,
    2. Li F,
    3. Li Z, et al

    . Time-dependent endovascular treatment effect according to collateral status in basilar artery occlusion. Neurotherapeutics 2022;20:220–29 doi:10.1007/s13311-022-01301-z pmid:36195697

    CrossRefPubMedGoogle Scholar
33. 33.↵
    1. Broocks G,
    2. Faizy TD,
    3. Meyer L, et al

    . Posterior circulation collateral flow modifies the effect of thrombectomy on outcome in acute basilar artery occlusion. Int J Stroke 2022;17:761–69 doi:10.1177/17474930211052262 pmid:34569885

    CrossRefPubMedGoogle Scholar
34. 34.↵
    1. Hayakawa M,
    2. Sugiu K,
    3. Yoshimura S, et al

    . Effectiveness of staged angioplasty for avoidance of cerebral hyperperfusion syndrome after carotid revascularization. J Neurosurg 2019;132:51–61 doi:10.3171/2018.8.JNS18887 pmid:30660130

    CrossRefPubMedGoogle Scholar
35. 35.↵
    1. Mori T,
    2. Yoshioka K,
    3. Tanno Y, et al

    . Intentional stent stenosis to prevent hyperperfusion syndrome after carotid artery stenting for extremely high-grade stenosis. AJNR Am J Neuroradiol 2021;42:132–37 doi:10.3174/ajnr.A6853 pmid:33184067

    Abstract/FREE Full TextGoogle Scholar
36. 36.↵
    1. Murai S,
    2. Sugiu K,
    3. Hishikawa T, et al

    . Safety and efficacy of staged angioplasty for patients at risk of hyperperfusion syndrome: a single-center retrospective study. Neuroradiology 2020;62:503–10 doi:10.1007/s00234-019-02343-5 pmid:31915841

    CrossRefPubMedGoogle Scholar
37. 37.↵
    1. Xu S,
    2. Sun B,
    3. Zhang T, et al

    . Staged carotid artery stenting for prevention of hyperperfusion-induced intracerebral hemorrhage in patients with very high-grade carotid stenosis and poor collateral compensation. World Neurosurg 2022;171:e38–46 doi:10.1016/j.wneu.2022.11.057 pmid:36396048

    CrossRefPubMedGoogle Scholar